Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -76,842 | -55,884 | -28,530 | -45,309 | -57,611 |
| Depreciation Amortization | 442 | 286 | 138 | 593 | 453 |
| Accounts receivable | N/A | 932 | 940 | -904 | N/A |
| Accounts payable and accrued liabilities | -502 | -3,385 | 1,848 | 499 | 2,187 |
| Other Working Capital | 14,059 | 5,990 | 10,492 | -33,023 | -2,000 |
| Other Operating Activity | 17,859 | 17,968 | 2,803 | 10,504 | 16,812 |
| Operating Cash Flow | $-44,984 | $-34,093 | $-12,309 | $-67,640 | $-40,159 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -70,060 | 117,412 | N/A |
| PPE Investments | -55 | -52 | -4 | -211 | -149 |
| Purchase Of Investment | N/A | -72,449 | 25,683 | -139,167 | N/A |
| Other Investing Activity | 5,401 | 26,558 | 0 | 0 | -87,942 |
| Investing Cash Flow | $5,346 | $-45,943 | $-44,381 | $-21,966 | $-88,091 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15 | 15 | 14 | 142,087 | 142,185 |
| Financing Cash Flow | $15 | $15 | $14 | $142,087 | $142,185 |
| Exchange Rate Effect | 324 | 430 | 232 | 60 | 219 |
| Beginning Cash Position | 121,330 | 121,330 | 121,330 | 68,789 | 68,789 |
| End Cash Position | 82,031 | 41,739 | 64,886 | 121,330 | 82,943 |
| Net Cash Flow | $-39,299 | $-79,591 | $-56,444 | $52,541 | $14,154 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,984 | -34,093 | -12,309 | -67,640 | -40,159 |
| Capital Expenditure | -55 | -52 | -4 | -211 | -149 |
| Free Cash Flow | -45,039 | -34,145 | -12,313 | -67,851 | -40,308 |